# Oculogica

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oculogica

- Industry: Medical Devices & Equipment
- Headquarters: New York, US
- Website: www.oculogica.com
- Total disclosed funding: $13M
- Latest round: Series B (Apr 26, 2024)
- Investors on record: 3

## About

Based in New York, US, and founded in 2013 by Uzma Samadani, Oculogica, Inc. specializes in concussion diagnosis and categorization, with the FDA-cleared technology that aids in the diagnosis of concussion without a pre-injury baseline test requirement. In May 2021, Oculogica, Inc. received USD 2 million of grant funding led by the US Army Medical Research and Material Command. Rosina Samandani is the CEO of the company. 

Oculogica, Inc. offers EyeBox, which is the FDA-cleared baseline-free aid in the diagnosis of concussion to help physicians objectively categorize concussion. This device provides a 4-minute test for ages between 5 to 67 and provides a Box Score to help physicians to determine the presence of a concussion. The company's product is used by various healthcare organizations, including the clinics of the President of the California Brain Injury Association, Midwest Orthopedics at Rush University, and others.

Oculogica, Inc. will use the funding to develop wearable concussion diagnostics with pre-eminent partners.

## Funding rounds

- Series B, Apr 26, 2024, $7.6M — Microsoft, TitletownTech Ventures
- Seed, Aug 28, 2018, $5M — Golden Seeds

## Investors

- Golden Seeds (https://capitalatlas.ai/funds/golden-seeds) — Seed
- Microsoft — Series B
- TitletownTech Ventures (https://capitalatlas.ai/funds/titletowntech-ventures) — Series B